SSRI Withdrawal Was Downplayed for Decades — Now Guidelines Are Being Rewritten

SSRIs were adopted as the safe successor to older antidepressants like tricyclics, trading serious cardiac and toxicity risks for milder side effects. That reputation for harmlessness had a downside: clinicians rarely revisited prescriptions, and a 2022 review found that no major national guideline (US, UK, Australia, Canada) offered concrete instructions on tapering or managing withdrawal. The result is entrenched long-term use — median US duration is now five years, with over a quarter of patients on the drugs a decade or more — despite the fact that the average clinical trial lasts only eight weeks, leaving long-term efficacy and withdrawal effects essentially unstudied.

A wave of recent research is forcing a rethink. Psychiatry researcher Mark Horowitz, who endured severe withdrawal — panic attacks, insomnia, dissociation — after tapering off escitalopram, co-authored surveys finding that roughly four-fifths of people who stop report withdrawal symptoms, with 43% experiencing them for over a year and one in four unable to quit at all. A broader 2024 analysis of 16,000+ patients put the withdrawal rate near 15% (highest for two SNRIs), with about 1 in 35 hitting severe symptoms. A recurring failure is diagnostic: physicians often misread withdrawal as relapse of the original depression, which is then used to justify restarting or raising the dose — a pattern one Harvard neuroscientist frames as gaslighting patients into indefinite treatment.

The concerns extend past withdrawal. Emerging observational work links long-term use to other harms, including a reported 74% higher risk of sudden cardiac death after six-plus years on the drugs, plus signals of faster cognitive decline in elderly and dementia patients. The takeaway isn’t that SSRIs don’t work — large analyses still show small-to-moderate benefit — but that decades of assumed safety produced sloppy prescribing practices, and both the clinical guidance and the patient monitoring around these drugs are now overdue for correction.